Peter J. Campbell

Wellcome Genome Campus - Cancer Genome Project

Hinxton, Saffron Walden

Cambridge, England CB10 1SA

United Kingdom

Wellcome Trust Sanger Institute

Hinxton, Saffron Walden

Cambridge, England CB10 1SA

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS

296

TOTAL CITATIONS

3

Scholarly Papers (3)

1.

Sequential Inverse Dysregulation of the RNA Helicases DDX3X and DDX3Y Facilitates MYC-Driven Lymphomagenesis

Number of pages: 68 Posted: 21 Jan 2020
Wellcome Trust and MRC Cambridge Stem Cell Institute, Wellcome Trust and MRC Cambridge Stem Cell Institute, Wellcome Trust and MRC Cambridge Stem Cell Institute, National University of Singapore (NUS) - Department of Haematology, The Babraham Institute, Wellcome Trust and MRC Cambridge Stem Cell Institute, University of Cambridge - Division of Cellular and Molecular Pathology, St. James’s Institute of Oncology - Haematological Malignancy Diagnostic Service, University of York - Epidemiology and Cancer Statistics Group, National University of Singapore (NUS) - Department of Haematology, Goethe University Frankfurt - Department of Medicine II, Hematology/Oncology, Wellcome Trust and MRC Cambridge Stem Cell Institute, The Francis Crick Institute, Nanyang Technological University (NTU) - School of Biological Sciences, Teesside University - School of Health & Life Sciences, Teesside University - School of Health & Life Sciences, University of Cambridge - Division of Cellular and Molecular Pathology, University of Cambridge - Division of Cellular and Molecular Pathology, National University of Singapore (NUS) - Department of Clinical Translational Research, Addenbrooke’s Hospital - Department of Paediatric Oncology, Nanyang Technological University (NTU) - School of Biological Sciences, Wellcome Trust Sanger Institute, St. James’s Institute of Oncology - Haematological Malignancy Diagnostic Service, Wellcome Genome Campus - Cancer Genome Project, Teesside University - School of Health & Life Sciences, University of Cambridge - Division of Cellular and Molecular Pathology, National Institute of Chemistry Slovenia, University of York - Epidemiology and Cancer Statistics Group, St. James’s Institute of Oncology - Haematological Malignancy Diagnostic Service, Goethe University Frankfurt - Department of Medicine II, Hematology/Oncology, The Babraham Institute - Immunology Programme, University of Cambridge - Division of Cellular and Molecular Pathology, University of Cambridge - MRC Cancer Unit and Wellcome Trust and MRC Cambridge Stem Cell Institute
Downloads 153 (395,722)
Citation 1

Abstract:

Loading...

Lymphoma, Translation, Cancer, MYCDDX3X

2.

Timing the Initiation of Multiple Myeloma

Number of pages: 122 Posted: 25 Jun 2019
Memorial Sloan Kettering Cancer Center - Myeloma Service, Memorial Sloan Kettering Cancer Center - Myeloma Service, University of Milan, Faculty of Medicine, Oncology and Hemato-Oncology Department, Wellcome Sanger Institute, University of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Essex, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, University of Milan, Faculty of Medicine, Oncology and Hemato-Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori - Division of Hematology and Bone Marrow Transplantation, University of Milan, Harvard University - Dana-Farber Cancer Institute, University of Nantes, Memorial Sloan Kettering Cancer Center - Myeloma Service, University of California, San Diego (UCSD) - Moores Cancer Center, University of Barcelona, Patologia Molecular de Neoplàsies Limfoides, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Ulm University, IUC-Oncopole, Memorial Sloan Kettering Cancer Center - Myeloma Service, Harvard University - Dana-Farber Cancer Institute, Wellcome Genome Campus - Cancer Genome Project and Memorial Sloan Kettering Cancer Center - Myeloma Service
Downloads 75 (650,227)
Citation 2

Abstract:

Loading...

Multiple Myeloma, Mutational Signatures, Molecular Time, Cancer Initiation, Germinal Center

3.

Undifferentiated Sarcomas Develop Through Distinct Evolutionary Pathways

Number of pages: 54 Posted: 02 Jul 2018
University College London, The Francis Crick Institute - Cancer Genomics Laboratory, Government of the United States of America - Theoretical Biology and Biophysics, University College London - Research Department of Pathology, Royal National Orthopaedic Hospital NHS Trust - Department of Cellular and Molecular Pathology, The Francis Crick Institute - Cancer Genomics Laboratory, University College London - Research Department of Pathology, Wellcome Sanger Institute, Wellcome Genome Campus - Cancer Genome Project, Wellcome Genome Campus - Cancer Genome Project, University College London - Research Department of Pathology, Royal National Orthopaedic Hospital NHS Trust - Department of Cellular and Molecular Pathology, University College London - Research Department of Pathology, Wellcome Genome Campus - Cancer Genome Project, Royal National Orthopaedic Hospital NHS Trust - Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust - Department of Cellular and Molecular Pathology, Wellcome Genome Campus - Cancer Genome Project, The Francis Crick Institute - Cancer Genomics Laboratory, University College London - Research Department of Pathology and University College London - Research Department of Pathology
Downloads 68 (684,437)

Abstract:

Loading...